SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-011106
Filing Date
2017-11-08
Accepted
2017-11-07 17:38:27
Documents
49
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20170930-10q.htm 10-Q 934882
2 EXHIBIT 31.1 ex-311x20170930.htm EX-31.1 12045
3 EXHIBIT 31.2 ex-312x20170930.htm EX-31.2 12073
4 EXHIBIT 32.1 ex-321x20170930.htm EX-32.1 11849
  Complete submission text file 0001628280-17-011106.txt   4197164

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgls-20170930.xml EX-101.INS 840805
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20170930.xsd EX-101.SCH 30778
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20170930_cal.xml EX-101.CAL 51368
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20170930_def.xml EX-101.DEF 143337
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20170930_lab.xml EX-101.LAB 424981
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20170930_pre.xml EX-101.PRE 237103
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 171184540
SIC: 2834 Pharmaceutical Preparations